Boel D. De Paepe-Paepe

Gent, VLG 9000, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Early Taurine Administration Decreases the Levels of Receptor-Interacting Serine/Threonine Protein Kinase 1 in the Duchenne Mouse Model mdx.

Early Taurine Administration Decreases the Levels of Receptor-Interacting Serine/Threonine Protein Kinase 1 in the Duchenne Mouse Model mdx.

Journal: Brain sciences

Published: September 16, 2025

Changes to the Autophagy-Related Muscle Proteome Following Short-Term Treatment with Ectoine in the Duchenne Muscular Dystrophy Mouse Model mdx.

Changes to the Autophagy-Related Muscle Proteome Following Short-Term Treatment with Ectoine in the Duchenne Muscular Dystrophy Mouse Model mdx.

Journal: International journal of molecular sciences

Published: November 15, 2024

Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.

Autoantibodies against a subunit of mitochondrial respiratory chain complex I in inclusion body myositis.

Journal: Journal of autoimmunity

Published: July 21, 2024

Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta-Analyses.

Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta-Analyses.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 12, 2024

Discovery of new myositis genetic associations through leveraging other immune-mediated diseases.

Discovery of new myositis genetic associations through leveraging other immune-mediated diseases.

Journal: HGG advances

Published: January 16, 2024

Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy.

Retrospective Study Shows That Serum Levels of Chemokine CXCL10 and Cytokine GDF15 Support a Diagnosis of Sporadic Inclusion Body Myositis and Immune-Mediated Necrotizing Myopathy.

Journal: Brain sciences

Published: September 04, 2023

mTOR Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells.

mTOR Inhibition Enhances Delivery and Activity of Antisense Oligonucleotides in Uveal Melanoma Cells.

Journal: Nucleic acid therapeutics

Published: June 30, 2023

What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models.

What Nutraceuticals Can Do for Duchenne Muscular Dystrophy: Lessons Learned from Amino Acid Supplementation in Mouse Models.

Journal: Biomedicines

Published: June 28, 2023

Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.

Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.

Journal: Rheumatology (Oxford, England)

Published: April 19, 2023

C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD.

C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD.

Journal: Acta neuropathologica

Published: December 29, 2022

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit.

Incorporating circulating cytokines into the idiopathic inflammatory myopathy subclassification toolkit.

Journal: Frontiers in medicine

Published: December 23, 2022

The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker.

The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker.

Journal: International journal of molecular sciences

Published: September 30, 2022

Showing 1-12 of 83

Last Updated: 09/26/2026